Sign in

CIK 0001157601 · Large accelerated filer

MADRIGAL PHARMACEUTICALS, INC.

Sign in to watch
Ticker
MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(267) 824-2827
Business address
1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
Former names
MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
Open-market buys, last 90 days
$35,023,032
in 1 filing
Open-market sales, last 90 days
$7,011,938
in 3 filings, $6.7M under 10b5-1 plans

Net +$28,011,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. BAKER BROS. ADVISORS LP +$35.0M Director 1 filing
  2. Sibold William John −$6.2M President and CEO sold 6% of stake
  3. Kelley Shannon T −$773K General Counsel sold 14% of stake
Date Insider Transaction Shares Price Value Owned after
2023-12-13 BAKER BROS. ADVISORS LP Director Purchase +10,894 $217.52 $2.4M 1,720,287
2023-12-13 BAKER BROS. ADVISORS LP Director Purchase +2,373 $218.46 $518K 182,521
2023-12-13 BAKER BROS. ADVISORS LP Director Purchase +29,738 $218.46 $6.5M 1,750,025
2023-12-13 BAKER BROS. ADVISORS LP Director Purchase +360 $219.87 $79K 182,881
2023-12-13 BAKER BROS. ADVISORS LP Director Purchase +4,518 $219.87 $993K 1,754,543
2023-12-13 BAKER BROS. ADVISORS LP Director Purchase +361 $221.78 $80K 183,242
2023-12-13 BAKER BROS. ADVISORS LP Director Purchase +4,532 $221.78 $1.0M 1,759,075
2023-12-13 BAKER BROS. ADVISORS LP Director Purchase +738 $222.68 $164K 183,980
2023-12-13 BAKER BROS. ADVISORS LP Director Purchase +9,262 $222.68 $2.1M 1,768,337
2023-12-13 BAKER BROS. ADVISORS LP Director Purchase +29 $223.94 $6K 184,009
2023-12-13 BAKER BROS. ADVISORS LP Director Purchase +363 $223.94 $81K 1,768,700
2023-12-13 BAKER BROS. ADVISORS LP Director Purchase +446 $224.91 $100K 184,455
2023-12-13 BAKER BROS. ADVISORS LP Director Purchase +5,594 $224.91 $1.3M 1,774,294
2023-12-13 Waltermire Robert E. Senior VP, Chief Pharma Dev. Option exercise +2,500 $87.92 $220K 8,167
2023-12-13 Waltermire Robert E. Senior VP, Chief Pharma Dev. Sale −1,500 $225.00 $338K 6,667
2023-12-13 Waltermire Robert E. Senior VP, Chief Pharma Dev. Sale −1,000 $226.00 $226K 5,667
2023-12-13 Waltermire Robert E. Senior VP, Chief Pharma Dev. Option exercise · Stock Option (Right to Buy) −2,500 21,200
2023-12-12 BAKER BROS. ADVISORS LP Director Purchase +7 $205.32 $1K 175,915
2023-12-12 BAKER BROS. ADVISORS LP Director Purchase +93 $205.32 $19K 1,667,197
2023-12-12 BAKER BROS. ADVISORS LP Director Purchase +56 $205.60 $12K 175,971

Page 39 of 82 · 1,629 trades